Janney Capital Management LLC Hutchmed (China) LTD Transaction History

Janney Capital Management LLC

$1.55 Billion
Q2 2025

A detailed history of Janney Capital Management LLC transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Janney Capital Management LLC holds 13,184 shares of HCM stock, worth $233,884. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,184

Previous 14,898 11.5%

Holding current value

$233,884

Previous $224,000 11.61%

% of portfolio

0.01%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	SELL	$11.81 - $17.72 $20,242 - $30,372	-1,714 Reduced 11.5%	13,184 $198,000
Q1 2025 Apr 21, 2025	SELL	$13.09 - $16.75 $6,414 - $8,207	-490 Reduced 3.18%	14,898 $224,000
Q4 2024 Jan 17, 2025	SELL	$14.25 - $21.35 $13,409 - $20,090	-941 Reduced 5.76%	15,388 $222,000
Q3 2024 Oct 29, 2024	SELL	$16.03 - $20.31 $10,563 - $13,384	-659 Reduced 3.88%	16,329 $319,000
Q2 2024 Jul 25, 2024	SELL	$16.36 - $21.78 $2,568 - $3,419	-157 Reduced 0.92%	16,988 $291,000
Q1 2024 May 01, 2024	BUY	$12.08 - $18.56 $5,556 - $8,537	460 Added 2.76%	17,145 $288,000
Q4 2023 Feb 07, 2024	SELL	$16.25 - $20.23 $8,417 - $10,479	-518 Reduced 3.01%	16,685 $302,000
Q3 2023 Nov 08, 2023	BUY	$11.85 - $16.95 $5,557 - $7,949	469 Added 2.8%	17,203 $291,000
Q2 2023 Jul 26, 2023	SELL	$10.78 - $17.73 $970 - $1,595	-90 Reduced 0.53%	16,734 $201,000
Q1 2023 Apr 28, 2023	BUY	$13.02 - $19.87 $23,396 - $35,706	1,797 Added 11.96%	16,824 $219,000
Q4 2022 Feb 01, 2023	SELL	$7.65 - $15.51 $10,151 - $20,581	-1,327 Reduced 8.11%	15,027 $222,000
Q3 2022 Oct 25, 2022	SELL	$8.63 - $15.52 $15,767 - $28,355	-1,827 Reduced 10.05%	16,354 $145,000
Q2 2022 Aug 03, 2022	SELL	$8.59 - $20.77 $7,705 - $18,630	-897 Reduced 4.7%	18,181 $230,000
Q1 2022 May 04, 2022	BUY	$15.52 - $35.65 $5,447 - $12,513	351 Added 1.87%	19,078 $361,000
Q4 2021 Jan 27, 2022	SELL	$28.89 - $35.33 $1,213 - $1,483	-42 Reduced 0.22%	18,727 $657,000
Q3 2021 Nov 01, 2021	SELL	$35.66 - $42.94 $17,081 - $20,568	-479 Reduced 2.49%	18,769 $687,000
Q2 2021 Jul 26, 2021	BUY	$23.7 - $39.27 $96,293 - $159,554	4,063 Added 26.76%	19,248 $756,000
Q1 2021 Apr 27, 2021	BUY	$27.01 - $36.8 $1,890 - $2,576	70 Added 0.46%	15,185 $429,000
Q4 2020 Jan 25, 2021	SELL	$27.51 - $34.36 $2,971 - $3,710	-108 Reduced 0.71%	15,115 $484,000
Q3 2020 Nov 06, 2020	SELL	$25.8 - $34.61 $7,043 - $9,448	-273 Reduced 1.76%	15,223 $492,000
Q2 2020 Jul 23, 2020	SELL	$17.65 - $28.05 $12,972 - $20,616	-735 Reduced 4.53%	15,496 $427,000
Q1 2020 Apr 30, 2020	BUY	$15.19 - $29.51 $45,964 - $89,297	3,026 Added 22.92%	16,231 $290,000
Q4 2019 Jan 21, 2020	SELL	$17.17 - $25.95 $18,165 - $27,455	-1,058 Reduced 7.42%	13,205 $331,000
Q3 2019 Oct 28, 2019	BUY	$17.84 - $22.69 $1,480 - $1,883	83 Added 0.59%	14,263 $254,000
Q2 2019 Jul 29, 2019	BUY	$22.0 - $31.78 $311,960 - $450,640	14,180 New	14,180 $312,000

Others Institutions Holding HCM

# of Institutions

Shares Held

6.43M

Call Options Held

9.9K

Put Options Held

9.6K

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.07B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Capital Management LLC with notifications on news.

Account

Janney Capital Management LLC Hutchmed (China) LTD Transaction History